ENTRY       D12154                      Drug
NAME        Mirzotamab (USAN/INN)
FORMULA     C6454H9874N1694O2020S42
EXACT_MASS  144773.0262
MOL_WEIGHT  144862.3252
SEQUENCE    (Heavy chain)
            EVQLQESGPG LVKPSETLSL TCAVTGYSIT SGYSWHWIRQ FPGNGLEWMG YIHSSGSTNY
            NPSLKSRISI SRDTSKNQFF LKLSSVTAAD TAVYYCAGYD DYFEYWGQGT TVTVSSASTK
            GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS
            LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKKVEPKSCD KTHTCPPCPA PEAAGGPSVF
            LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR
            VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL PPSREEMTKN
            QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT VDKSRWQQGN
            VFSCSVMHEA LHNHYTQKSL SLSPGK
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCKASQNVG FNVAWYQQKP GKSPKALIYS ASYRYSGVPS
            RFSGSGSGTD FTLTISSLQP EDFAEYFCQQ YNWYPFTFGQ GTKLEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H143-H199, H219-L214, H225-H'225, H228-H'228, H260-H320, H366-H424, H'22-H'96, H'143-H'199, H'219-L'214, H'260-H'320, H'366-H'424, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-CD276 antibody
  TYPE      Monoclonal antibody
TARGET      CD276 [HSA:80381] [KO:K06746]
  PATHWAY   hsa04514(80381)  Cell adhesion molecules
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD276
                 D12154  Mirzotamab (USAN/INN)
DBLINKS     CAS: 2229859-11-2
///
